McClain v. Sav-On Drugs

9 Cal. App. 5th 684, 215 Cal. Rptr. 3d 416, 2017 WL 958377, 2017 Cal. App. LEXIS 217
CourtCalifornia Court of Appeal
DecidedMarch 13, 2017
DocketB265011, B265029
StatusPublished
Cited by16 cases

This text of 9 Cal. App. 5th 684 (McClain v. Sav-On Drugs) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McClain v. Sav-On Drugs, 9 Cal. App. 5th 684, 215 Cal. Rptr. 3d 416, 2017 WL 958377, 2017 Cal. App. LEXIS 217 (Cal. Ct. App. 2017).

Opinion

Opinion

HOFFSTADT, J.

—A customer buys skin puncture lancets and test strips used by diabetics to test blood glucose levels from a retail pharmacy store like CVS or Walgreens. The retail pharmacy is the one obligated to pay sales tax to the State of California (Rev. & Tax. Code, § 6051), 1 and accordingly charges the customer a “sales tax reimbursement,” to cover the cost of the sales tax, and remits that amount to the state. If the retail pharmacy subsequently believes no sales tax is owed, it—as the taxpayer—can file an administrative claim for a refund with the State Board of Equalization (the Board) and challenge any adverse ruling in court. (§§ 6901, 6932.) But the retail pharmacy usually has no financial incentive to pursue such a remedy because any refund it obtains from the Board must be passed back to the customer. (§ 6901.5; Decorative Carpets, Inc. v. State Board of Equalization (1962) 58 Cal.2d 252, 254-255 [23 Cal.Rptr. 589, 373 P.2d 637] (Decorative Carpets).) What is more, and as our Supreme Court recently reaffirmed in Loeffler v. Target Corp. (2014) 58 Cal.4th 1081, 1123-1124 [171 Cal.Rptr.3d 189, 324 P.3d 50] (Loeffler), the customer is not the taxpayer and thus cannot herself seek a refund from the Board.

May the customer obtain a court order compelling the retail pharmacy to file an administrative refund claim with the Board? Our Constitution strictly limits refund actions to those “provided by [our] Legislature” (Cal. Const., art. XIII, § 32), and no such statutory remedy exists. However, our Supreme Court in Javor v. State Board of Equalization (1974) 12 Cal.3d 790, 802 [117 Cal.Rptr. 305, 527 P.2d 1153] {Javor) held that the Legislature’s authority in this regard is not exclusive and that courts retain a residual power to fill remedial gaps by fashioning tax refund remedies in “unique circumstances.” Loeffler had no occasion to define those “unique circumstances.” (Loeffler, supra, 58 Cal.4th at pp. 1101, 1133-1134.)

*690 This case squarely presents this unanswered question. We conclude that a court may create a new tax refund remedy—and, accordingly, that the requisite “unique circumstances” exist—only if (1) the person seeking the new tax refund remedy has no statutory tax refund remedy available to it, (2) the tax refund remedy sought is not inconsistent with existing tax refund remedies, and (3) the Board has already determined that the person seeking the new tax refund remedy is entitled to a refund, such that the refusal to create that remedy will unjustly enrich either the taxpayer/retailer or the Board. Here, a group of customers filed a class action predicated on their ability to obtain an order compelling the retail pharmacies to file an administrative claim with the Board seeking a refund of the sales tax paid for skin puncture lancets and glucose test strips. Because the Revenue and Taxation Code does not provide for this remedy, and because they have not established any of the three prerequisites to the exercise of the judicial residual power to fashion new remedies, the trial court correctly sustained demurrers to all of the claims in the customers’ operative complaint without leave to amend. We consequently affirm the judgment below.

FACTS AND PROCEDURAL BACKGROUND

I. Facts

Plaintiffs and appellants Michael McClain, Avi Feigenblatt, and Gregory Fisher (collectively, customers) each bought skin puncture lancets and glucose test strips from retail pharmacy stores owned and/or operated by defendants and respondents Sav-On Drugs, Gavin Herbert Company, Longs Drug Stores Corporation, Longs Drug Stores California, Inc., Rite Aid Corporation, Walgreen Co., Target Corporation, Albertson’s Inc., The Vons Companies, Inc., Vons Food Services, Inc., and Wal-Mart Stores, Inc. (collectively, the retail pharmacies). Skin puncture lancets (or lancets) and glucose test strips are used by persons living with diabetes to draw their blood and test its glucose level, which is critical to knowing when to inject insulin to reduce their glucose levels. When the customers purchased lancets and test strips from the retail pharmacies, the retail pharmacies charged them “sales tax” on those items. The retail pharmacies subsequently remitted the money they collected as sales tax to the Board.

II. Procedural History

In the operative fourth amended complaint filed in 2014, 2 the customers sued the retail pharmacies and the Board 3 for a refund of the “sales tax” they *691 paid for lancets and test strips, alleging that these items have been exempt from sales tax since March 10, 2000, the date on which the Board made effective California Code of Regulations, title 18, section 1591.1, subdivision (b)(5) (Regulation 1591.1). This complaint sought to certify a class comprised of “all persons who were charged by and paid one or more of the [retail pharmacies] a sales tax on glucose test strips or skin puncture lancets in California when such should not have been charged.”

The operative complaint alleges that the retail pharmacies collected sales tax reimbursement for lancets and test strips when no sales tax was due on these items and that this conduct: (1) breached an implied term of the contract that is deemed by statute to exist whenever a retailer collects a sales tax reimbursement from a customer under Civil Code section 1656.1 and also breached the implied covenant of good faith and fair dealing; (2) constituted an unlawful, unfair and/or fraudulent business practice and thereby violates the unfair competition law (UCL) (Bus. & Prof. Code, § 17200 et seq.); (3) constituted negligence; and (4) violated the Consumers Legal Remedies Act (Civ. Code, § 1750 et seq.) by misrepresenting the taxability of those items. The operative complaint further seeks declaratory and injunctive relief compelling the retail pharmacies to prosecute a tax refund claim with the Board and the Board to award such a refund.

The retail pharmacies and the Board demurred to the operative complaint. Following briefing, the trial court issued an oral ruling sustaining the demurrers to all of the claims in the operative complaint without leave to amend. The court reasoned that Loeffler, supra, 58 Cal.4th 1081 held that a customer could not seek a tax refund of sales tax from a retailer; that Javor, supra, 12 Cal.3d 790 allowed a customer to seek a refund of sales tax where the Board had already decided the question of taxability and concluded that a refund was due; and that “[t]his case is more like Loeffler than Javor' because the taxability of lancets and test strips was “very hotly in dispute.”

Following entry of judgment, the customers filed this timely appeal.

*692 DISCUSSION

I. Pertinent Legal Principles

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Varuna Entertainment v. Ball CA2/2
California Court of Appeal, 2024
Michelman v. City of L.A. CA2/2
California Court of Appeal, 2022
County Inmate Telephone Service Cases
California Court of Appeal, 2020
Shaeffer v. Califia Farms, LLC
California Court of Appeal, 2020
McClain v. Sav-On Drugs
435 P.3d 424 (California Supreme Court, 2019)
Littlejohn v. Costco Wholesale Corp.
California Court of Appeal, 2018
Littlejohn v. Costco Wholesale Corp.
235 Cal. Rptr. 3d 608 (California Court of Appeals, 5th District, 2018)
Laquer v. Priceline Grp., Inc.
Second Circuit, 2018
Schep v. Capital One
California Court of Appeal, 2017
Schep v. Capital One, N.A.
220 Cal. Rptr. 3d 408 (California Court of Appeals, 5th District, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
9 Cal. App. 5th 684, 215 Cal. Rptr. 3d 416, 2017 WL 958377, 2017 Cal. App. LEXIS 217, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mcclain-v-sav-on-drugs-calctapp-2017.